ARS Pharmaceuticals, Inc. (SPRY) vs YD Bio Limited Ordinary Shares (YDES)

A side-by-side comparison of ARS Pharmaceuticals, Inc. and YD Bio Limited Ordinary Shares across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare
ARS Pharmaceuticals, Inc. logo
SPRY
ARS Pharmaceuticals, Inc.
$427M
$4.30HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
YD Bio Limited Ordinary Shares logo
YDES
YD Bio Limited Ordinary Shares
$436M
$6.15HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT

Total return — SPRY vs YDES

growth of $100 · dividends reinvested · last 1y
SPRY -75.9% (-75.9%/yr)YDES -40.9% (-40.9%/yr)YDES compounded faster over this window
50100150200Start $1002026$24$59
SPRY YDES

SPRY vs YDES: by the numbers

  • •YDES is the larger company ($436M vs $427M market cap).
  • •Both run net losses; SPRY's is the smaller (-184.24% vs -1392.61% net margin).

Metrics side by side

Valuation

MetricSPRYYDES
P/S ratio3.65N/A
P/B ratio34.09N/A

Profitability

MetricSPRYYDES
Gross margin73.89%-7.06%
Operating margin-212.92%-883.31%
Net margin-184.24%-1392.61%
ROE-1721.80%-66.49%
ROIC-114.65%N/A

Growth (annualized)

MetricSPRYYDES
Revenue CAGR (5Y)36.43%N/A
Total return CAGR (5Y)-16.35%N/A

Go deeper

Full SPRY analysisFull YDES analysisInteractive comparison tool

Dig into the metrics

ARS Pharmaceuticals ROEYD Bio Limited Ordinary Shares ROEARS Pharmaceuticals operating marginYD Bio Limited Ordinary Shares operating marginARS Pharmaceuticals revenue growthYD Bio Limited Ordinary Shares revenue growthARS Pharmaceuticals free cash flowYD Bio Limited Ordinary Shares free cash flow

ARS Pharmaceuticals & YD Bio Limited Ordinary Shares appear in these rankings

Fastest Revenue Growth Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.